Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 05/01/26
Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now?Zacks Investment Research • 04/30/26
Unlocking Q1 Potential of Illumina (ILMN): Exploring Wall Street Estimates for Key MetricsZacks Investment Research • 04/29/26
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflowsPRNewsWire • 04/16/26
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare diseasePRNewsWire • 04/14/26
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026PRNewsWire • 04/09/26
The Personalized Biotech Flywheel Cathie Wood Built Is Still a Winning Bet Today24/7 Wall Street • 04/03/26
Illumina and Labcorp expand collaboration to broaden access to precision oncology testingPRNewsWire • 03/18/26
Illumina advances preventive genomics through strategic consortium with Veritas GeneticsPRNewsWire • 03/16/26
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offeringPRNewsWire • 03/05/26
Illumina, Inc. (ILMN) Presents at TD Cowen 46th Annual Health Care Conference TranscriptSeeking Alpha • 03/04/26
Illumina whole-genome sequencing technology to accelerate rare disease testing in FloridaPRNewsWire • 02/27/26
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026Business Wire • 02/26/26
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomicsPRNewsWire • 02/25/26
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibilityPRNewsWire • 02/23/26